Increased Circulating Epithelial Tumor Cells (CETC/CTC) over the Course of Adjuvant Radiotherapy Is a Predictor of Less Favorable Outcome in Patients with Early-Stage Breast Cancer.
Matthias A MäurerDorothea SchottMonika PizonSonia DrozdzThomas WendtAndrea WittigKatharina PachmannPublished in: Current oncology (Toronto, Ont.) (2022)
The trial is registered (2 May 2019) at trials.gov under NCT03935802.